maprotiline has been researched along with Parkinson Disease in 5 studies
Maprotiline: A bridged-ring tetracyclic antidepressant that is both mechanistically and functionally similar to the tricyclic antidepressants, including side effects associated with its use.
Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (60.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lauterbach, EC | 1 |
Victoroff, J | 1 |
Coburn, KL | 1 |
Shillcutt, SD | 1 |
Doonan, SM | 1 |
Mendez, MF | 1 |
Lefebvre, H | 1 |
Noblet, C | 1 |
Moore, N | 1 |
Wolf, LM | 1 |
Baykoushev, S | 2 |
Hadjipetrova, E | 1 |
Temenlieva, V | 2 |
Sandyk, R | 1 |
1 review available for maprotiline and Parkinson Disease
Article | Year |
---|---|
Psychopharmacological neuroprotection in neurodegenerative disease: assessing the preclinical data.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Antipsychotic Agents; Benzodiazepines; Benzo | 2010 |
4 other studies available for maprotiline and Parkinson Disease
Article | Year |
---|---|
Pseudo-phaeochromocytoma after multiple drug interactions involving the selective monoamine oxidase inhibitor selegiline.
Topics: Bronchial Spasm; Bronchitis; Depressive Disorder; Diagnosis, Differential; Drug Interactions; Ephedr | 1995 |
Ludiomil in the treatment of parkinsonism.
Topics: Aged; Electromyography; Female; Humans; Male; Maprotiline; Middle Aged; Parkinson Disease | 1989 |
Ludiomil in parkinsonism (EMG and clinical study).
Topics: Anthracenes; Antidepressive Agents; Electromyography; Female; Humans; Male; Maprotiline; Parkinson D | 1987 |
Maprotiline for disordered cognitive function in Parkinson's disease.
Topics: Anthracenes; Cognition Disorders; Humans; Male; Maprotiline; Middle Aged; Parkinson Disease | 1986 |